In the new trial, researchers will inject the three genes into one eye using a modified virus. Patients will then take an ...
A Survival God for the Age of Abundance,” Peter H. Diamandis and Steven Kotler explore what it means to be human in a world ...
First study of agenT-797, botensilimab (BOT) and balstilimab (BAL) in gastroesophageal cancer shows disease control rate (DCR) in 77% of patients ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced data from an investigator-initiated Phase II trial at Memorial Sloan Kettering Cancer Center, investigating ...
Surveillance video captured suspects climbing into a Chicago business. Two teenagers are now facing charges for the break-in ...
Feet often symbolize "movement, progress, service and grounding," she states.
Asgard’s immunotherapy, AT-108, induces systemic, dose-dependent efficacy with broad tumor activity in preclinical studies ...
Researchers showed that an experimental therapy indirectly converted suppressive immune cells into tumor-fighting cells. This ...
A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
Will Spider-Man cross a moral line in Amazing Spider-Man #27? DEATH SPIRAL concludes as Torment pushes our hero to the ...
An innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins—including ...
The data to be presented show that Geminii's bioelectronic therapy slowed tumor growth, extended survival, and enhanced the activity of chemoradiation in multiple preclinical NSCLC models without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results